These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 38950871)

  • 1. Glucocorticoid receptors orchestrate a convergence of host and cellular stress signals in triple negative breast cancer.
    Posani SH; Gillis NE; Lange CA
    J Steroid Biochem Mol Biol; 2024 Oct; 243():106575. PubMed ID: 38950871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid receptors are required effectors of TGFβ1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer.
    Perez Kerkvliet C; Dwyer AR; Diep CH; Oakley RH; Liddle C; Cidlowski JA; Lange CA
    Breast Cancer Res; 2020 May; 22(1):39. PubMed ID: 32357907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress sensing within the breast tumor microenvironment: how glucocorticoid receptors live in the moment.
    Kerkvliet CP; Truong TH; Ostrander JH; Lange CA
    Essays Biochem; 2021 Dec; 65(6):971-983. PubMed ID: 34132331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis.
    Regan Anderson TM; Ma S; Perez Kerkvliet C; Peng Y; Helle TM; Krutilina RI; Raj GV; Cidlowski JA; Ostrander JH; Schwertfeger KL; Seagroves TN; Lange CA
    Mol Cancer Res; 2018 Nov; 16(11):1761-1772. PubMed ID: 29991529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid Receptors Drive Breast Cancer Cell Migration and Metabolic Reprogramming via PDK4.
    Dwyer AR; Perez Kerkvliet C; Truong TH; Hagen KM; Krutilina RI; Parke DN; Oakley RH; Liddle C; Cidlowski JA; Seagroves TN; Lange CA
    Endocrinology; 2023 Jun; 164(7):. PubMed ID: 37224504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer.
    Regan Anderson TM; Ma SH; Raj GV; Cidlowski JA; Helle TM; Knutson TP; Krutilina RI; Seagroves TN; Lange CA
    Cancer Res; 2016 Mar; 76(6):1653-63. PubMed ID: 26825173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling.
    Galliher-Beckley AJ; Williams JG; Cidlowski JA
    Mol Cell Biol; 2011 Dec; 31(23):4663-75. PubMed ID: 21930780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid receptor-mediated oncogenic activity is dependent on breast cancer subtype.
    Clark AB; Conzen SD
    J Steroid Biochem Mol Biol; 2024 Oct; 243():106518. PubMed ID: 38734115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Tumor Kinase (Brk/PTK6) Mediates Advanced Cancer Phenotypes via SH2-Domain Dependent Activation of RhoA and Aryl Hydrocarbon Receptor (AhR) Signaling.
    Dwyer AR; Kerkvliet CP; Krutilina RI; Playa HC; Parke DN; Thomas WA; Smeester BA; Moriarity BS; Seagroves TN; Lange CA
    Mol Cancer Res; 2021 Feb; 19(2):329-345. PubMed ID: 33172975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling.
    Kanai A; McNamara KM; Iwabuchi E; Miki Y; Onodera Y; Guestini F; Khalid F; Sagara Y; Ohi Y; Rai Y; Yamaguchi R; Tanaka M; Miyashita M; Ishida T; Sasano H
    Breast Cancer Res Treat; 2020 Feb; 180(1):97-110. PubMed ID: 31989378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid receptor overexpression slightly shifts microRNA expression patterns in triple-negative breast cancer.
    Buschmann D; González R; Kirchner B; Mazzone C; Pfaffl MW; Schelling G; Steinlein O; Reithmair M
    Int J Oncol; 2018 Jun; 52(6):1765-1776. PubMed ID: 29620157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer.
    Skor MN; Wonder EL; Kocherginsky M; Goyal A; Hall BA; Cai Y; Conzen SD
    Clin Cancer Res; 2013 Nov; 19(22):6163-72. PubMed ID: 24016618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3 and GR Cooperate to Drive Gene Expression and Growth of Basal-Like Triple-Negative Breast Cancer.
    Conway ME; McDaniel JM; Graham JM; Guillen KP; Oliver PG; Parker SL; Yue P; Turkson J; Buchsbaum DJ; Welm BE; Myers RM; Varley KE
    Cancer Res; 2020 Oct; 80(20):4355-4370. PubMed ID: 32816914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast Cancer.
    Agyeman AS; Jun WJ; Proia DA; Kim CR; Skor MN; Kocherginsky M; Conzen SD
    Horm Cancer; 2016 Apr; 7(2):114-26. PubMed ID: 26858237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis.
    Paul A; Gunewardena S; Stecklein SR; Saha B; Parelkar N; Danley M; Rajendran G; Home P; Ray S; Jokar I; Vielhauer GA; Jensen RA; Tawfik O; Paul S
    Cell Death Differ; 2014 Sep; 21(9):1469-81. PubMed ID: 24786829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.
    Chen X; Iliopoulos D; Zhang Q; Tang Q; Greenblatt MB; Hatziapostolou M; Lim E; Tam WL; Ni M; Chen Y; Mai J; Shen H; Hu DZ; Adoro S; Hu B; Song M; Tan C; Landis MD; Ferrari M; Shin SJ; Brown M; Chang JC; Liu XS; Glimcher LH
    Nature; 2014 Apr; 508(7494):103-107. PubMed ID: 24670641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
    Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
    Front Immunol; 2019; 10():804. PubMed ID: 31105691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRE1α Disruption in Triple-Negative Breast Cancer Cooperates with Antiangiogenic Therapy by Reversing ER Stress Adaptation and Remodeling the Tumor Microenvironment.
    Harnoss JM; Le Thomas A; Reichelt M; Guttman O; Wu TD; Marsters SA; Shemorry A; Lawrence DA; Kan D; Segal E; Merchant M; Totpal K; Crocker LM; Mesh K; Dohse M; Solon M; Modrusan Z; Rudolph J; Koeppen H; Walter P; Ashkenazi A
    Cancer Res; 2020 Jun; 80(11):2368-2379. PubMed ID: 32265225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of SGK1 via glucocorticoid-influenced clinical outcome of triple-negative breast cancer patients.
    Zhang J; Miki Y; Iwabuchi E; Xu J; Kanai A; Sagara Y; Ohi Y; Rai Y; Yamaguchi R; Tanaka M; Ishida T; Suzuki T; Sasano H
    Breast Cancer Res Treat; 2023 Aug; 200(3):323-335. PubMed ID: 37286891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
    Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
    Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.